Cargando…
Verdinexor, a Selective Inhibitor of Nuclear Exportin 1, Inhibits the Proliferation and Migration of Esophageal Cancer via XPO1/c-Myc/FOSL1 Axis
Esophageal carcinoma (EC) ranks sixth among cancers in mortality worldwide and effective drugs to reduce EC incidence and mortality are lacking. To explore potential anti-esophageal cancer drugs, we conducted drug screening and discovered that verdinexor, a selective inhibitor of nuclear exportin 1...
Autores principales: | Ou, Ling, Wang, Xinyou, Cheng, Shumin, Zhang, Min, Cui, Ruiqin, Hu, Chunxia, Liu, Shiyi, Tang, Qian, Peng, Yuying, Chai, Ruihuan, Xie, Shouxia, Wang, Shaoxiang, Huang, Wei, Wang, Xiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692140/ https://www.ncbi.nlm.nih.gov/pubmed/34975332 http://dx.doi.org/10.7150/ijbs.66612 |
Ejemplares similares
-
In vitro toxicity and efficacy of verdinexor, an exportin 1 inhibitor, on opportunistic viruses affecting immunocompromised individuals
por: Widman, Douglas G., et al.
Publicado: (2018) -
XPO1/CRM1 is a promising prognostic indicator for neuroblastoma and represented a therapeutic target by selective inhibitor verdinexor
por: Pan, Lijia, et al.
Publicado: (2021) -
Induction of p53-mediated transcription and apoptosis by exportin-1 (XPO1) inhibition in mantle cell lymphoma
por: Yoshimura, Mariko, et al.
Publicado: (2014) -
A method for quantification of exportin-1 (XPO1) occupancy by Selective Inhibitor of Nuclear Export (SINE) compounds
por: Crochiere, Marsha L., et al.
Publicado: (2015) -
XPO1(E571K) Mutation Modifies Exportin 1 Localisation and Interactome in B-Cell Lymphoma
por: Miloudi, Hadjer, et al.
Publicado: (2020)